H. Kondo

UDP-glucuronosyltransferase (UGT) 1A1*28 polymorphism-directed phase II study of irinotecan with 5'-deoxy-5-fluorouridine (5'-DFUR) for metastatic colorectal cancer.

M. Oka, Y. Hinoda, S. Hazama, 2013, Anticancer research.

Tumor-to-tumor metastasis: an extremely rare combination with renal cell carcinoma as the donor and a pancreatic neuroendocrine tumor as the recipient

T. Misawa, M. Shibuya, K. Sano, 2022, Surgical Case Reports.

Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism

M. Oka, Y. Hinoda, S. Hazama, 2010, Cancer science.

Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.

M. Oka, Y. Hinoda, S. Hazama, 2008, Anticancer research.

SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers

Mindy I. Davis, Patricia Greninger, C. Benes, 2023, Nature Cancer.

A genetic UGT1A1 polymorphism oriented phase I study of irinotecan (CPT-11) and doxifluridine (5'-DFUR: An intermediate form of capecitabine for metastatic colorectal cancer (MCRC).

M. Oka, Y. Hinoda, S. Hazama, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.